Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

A gathering of global perspectives… a look at DIA’s annual meeting: Post 2 of 2

Posted on July 18th, 2016 by in Pharma R&D

As referenced in my last post, the Drug Information Association (DIA), held its annual conference in Philadelphia at the end of June with this year’s theme being “A Gathering of Global Perspectives.” In follow-up to that post, I want to share with you what I gleaned from two additional noteworthy sessions. (more…)

Advancing the Development and Clinical Use of Biomarkers

Posted on June 21st, 2016 by in Pharma R&D

Biomarker-based patient selection for clinical trials, a hallmark of precision medicine, is gaining traction. On Monday June 6, a team of researchers reported at the American Society of Clinical Oncology annual meeting and in an online paper in JAMA Oncology that biomarker selection results in better outcomes in Phase l trials. (more…)

More Drugs, Fewer Patients: Limits of Precision Medicine

Posted on November 9th, 2015 by in Chemistry

A number of targeted medications that are highly effective for a subgroup of patients with a particular disease have emerged in the last decade. These are often needed alternatives to debilitating therapies with uncertain outcomes. The small number of patients that benefit from such therapies, however, may pose a serious challenge looking into the future. (more…)

  1. 1
  2. 3
  3. 4
  4. 5